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Background: The ‘hot cross bun’ (HCB) sign refers to a cruciform-shaped hyperintensity within the pons found on
T2-weighted magnetic resonance imaging (MRI). It is commonly associated with atrophy of the pons, cerebellum,
and putamen in multiple system atrophy (MSA). In this report, we describe a rare case of the HCB sign in an adult
female patient with leptomeningeal metastases of breast cancer without any signs of brain atrophy.
Case presentation: The patient was a 58-year-old woman diagnosed with grade 2 ductal breast carcinoma, who
had undergone a right mastectomy, followed by chemotherapy treatments and chest wall radiotherapy. The tumor had
metastasized to the skin, and the patient presented with vomiting, drowsiness, and intermittent episodes of confusion,
slurred speech, and involuntary movements. Immunohistochemical staining demonstrated a triple-negative status of the
tumor. Axial T1-weighted MRI showed a linear enhancement in the cerebellar sulcus. A diagnosis of leptomeningeal
metastases of breast cancer was confirmed by detection of tumor cells in the cerebrospinal fluid. Axial T2-weighted MRI
indicated a cruciform hyperintensity in the pons without any atrophy of the pons, cerebellum, or putamen.
Conclusion: The HCB sign can occur with leptomeningeal metastases of solid tumors, though the underlying
mechanisms remain unknown.
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The ‘hot cross bun’ (HCB) sign is typically seen as a cru-
ciform hyperintensity in the pons on T2-weighted mag-
netic resonance imaging (MRI) of the brain. It is
commonly associated with atrophy of the pons, cerebel-
lum, and putamen [1], due to a selective loss of trans-
verse pontocerebellar fibers and neurons of the pontine
raphe, with preservation of corticospinal tracts and teg-
mental neurons [2]. Although the HCB sign is seen
more often in multiple system atrophy (MSA), its ap-
pearance has also been associated with brain atrophy in
a variety of neurodegenerative diseases, such as cerebro-
tendinous xanthomatosis [3], human immunodeficiency
virus-related progressive multifocal leukoencephalopathy
[4], variant Creutzfeldt-Jakob disease [5], spinocerebellar* Correspondence: drlhdong@163.com
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unless otherwise stated.ataxia [6], and with Parkinsonism secondary to pre-
sumed vasculitis, where it is thought to reflect Wallerian
degeneration of transverse pontocerebellar fibers [7].
The mechanisms underlying the HCB sign remain un-
clear and likely differ among the various diseases.
Here, we report a rare case of the HCB sign in a pa-
tient with breast cancer leptomeningeal metastases who
showed no detectable signs of brain atrophy. We also
explore the pathogenesis of the HCB sign.
Case presentation
A 58-year-old woman previously diagnosed with breast
cancer presented to our hospital with a 7- to 10-day his-
tory of progressively worsening intermittent headaches,
vomiting, drowsiness, episodes of confusion, slurred
speech, and involuntary movements. The patient had
undergone a right mastectomy for a breast tumor
18 months earlier. The tumor size (3.7 × 2.5 × 2.0 cm)
and type (grade 2 invasive ductal breast carcinoma) were
determined by postoperative pathologic analysis. Inis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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necrotic tissue, exhibited infiltrative growth, and was in-
filtrated with lymph cells (in a scattered pattern). Vascu-
lar thrombosis and right axillary lymph node metastasis
(5/15) were observed. Immunohistologic staining dem-
onstrated a triple-negative status (for estrogen and pro-
gesterone receptors, and human epidermal growth factor
receptor 2) and a high (60%) Ki-67 percentage. The
patient underwent six 21-day cycles of adjuvant chemo-
therapy with docetaxel (140 mg q.d.) and tetrahydropyr-
anyl adriamycin (70 mg b.i.d.) followed by chest wall
radiotherapy. The patient exhibited skin redness, ulcer-
ation, and a painful purulent discharge on the right chest
wall 4 months after the radiation therapy. Subsequently,
the size of the lesion gradually increased. Skin biopsy
and pathologic analysis indicated metastatic carcinoma
of breast cancer. The patient received five 21-day cycles
of chemotherapy with paclitaxel (150 mg q.d.) and car-
boplatin (300 mg q.d.). After three of these cycles, the
size of the lesion had reduced slightly. Upon review, theFigure 1 Magnetic resonance imaging (MRI) revealed the hot cross bu
in the left cerebellar hemisphere; no enhancement was observed on contrast
MRI showing diffuse linear enhancement in the cerebellar sulcus, suggesting
showing a cruciform hyperintensity in the pons; no atrophy was observed in
with gadolinium-based contrast agents.clinical response to chemotherapy was evaluated as a
stable disease.
The patient was presented at our clinic 2 weeks after the
last chemotherapy dose and was admitted to our hospital.
History taking at intake did not reveal any chronic dis-
eases, and she was confused and uncooperative during the
initial physical examination. A computed tomography scan
of the head demonstrated no abnormalities. Diffusion-
weighted MRI exhibited a patchy hyperintensity in the bi-
lateral cerebellar hemispheres (Figure 1A), but no contrast
enhancement was observed on contrast-enhanced MRI
(Figure 1B). Axial T1-weighted MRI indicated a diffuse
linear enhancement in the cerebellar sulcus, suggesting
leptomeningeal metastases of breast cancer (Figure 1C). A
cruciform-shaped hyperintensity appeared in the pons on
axial T2-weighted MRI (Figure 1D). There were no abnor-
malities of the ventricular system or shift of the midline
structures observed.
The patient was diagnosed with lacunar infarction in
bilateral cerebellar hemispheres and leptomeningealn sign. (A) Diffusion-weighted MRI showing a patchy hyperintensity
-enhanced MRI (B), suggesting cerebral infarction. (C) Axial T1-weighted
leptomeningeal metastases of breast cancer. (D) Axial T2-weighted MRI
the pons or cerebellum. All contrast-enhanced imaging was carried out
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performed, followed by cerebrospinal fluid (CSF) ana-
lysis, which revealed a CSF pressure of 380 mm H2O.
Total protein, glucose, and chloride concentrations were
0.69 g/L (normal range: 0.15 to 0.45 g/L), 2.11 mmol/L
(normal range: 2.3 to 4.3 mmol/L), and 109.9 mmol/L
(normal range: 119 to 129 mmol/L), respectively. More-
over, breast cancer cells were detected in the CSF follow-
ing cytologic evaluation of the fluid (Figure 2). The
disease rapidly progressed, and the patient went into a
shallow coma with unequal pupil size, left lower extrem-
ity muscle strength of 3/5, and a positive pathologic re-
flex. The patient remained in a coma state (Glasgow
Coma Scale score: 9) the day after her lumbar puncture
and was discharged without any treatment.
Discussion
Mechanisms have been proposed to explain the appear-
ance of the HCB sign, including selective degeneration
of pontine fibers in MSA [2], Parkinsonism secondary to
presumed vasculitis [7], and cerebrotendinous xantho-
matosis [3]. In addition, gliosis in pontocerebellar fibers
in the middle part of the reticular formation combined
with neuronal loss can produce the HCB sign on T2-
weighted MRI [8]. However, the HCB sign was observed
in the present case in the absence of any apparent cere-
bellar, pontine, or putaminal atrophy, indicating it can
also appear in other diseases, such as leptomeningeal
metastases from breast cancer.
Zhang et al. [9] reported the HCB sign in a case of
malignant melanoma, where the patient had a history of
epilepsy since childhood and exhibited signs of atrophy
in the pons and cerebellum. The appearance of the HCBFigure 2 Presence of tumor cells present in the cerebrospinal
fluid. A papanicolaou-stained, liquid-based, thin-layer preparation of
cerebrospinal fluid is shown (400×). Tumor cells were of various
large sizes, appeared clustered together, and had abnormal ratios of
nucleus (dark blue) to cytoplasm (light blue). The features suggested
adenocarcinoma cells.sign in that case may have been a result of epilepsy-
associated vasospasm and neuronal hypoxia. In the
current case, however, the patient had no prior history
of any chronic diseases. To date, there are no other re-
ports in the publicly available literature on HCB signs in
patients with primary tumors or secondary brain tumors.
The patient in the current case was diagnosed with
breast cancer leptomeningeal metastases based on her
history of breast cancer, neuroradiologic findings, clin-
ical manifestations, and results of CSF cytologic analysis,
which represent the gold standard for diagnosis [10].
Leptomeningeal metastases are from infiltration of
tumor cells into the pia or arachnoid mater and their
subsequent diffusion into the subarachnoid space. They
are considered rare, devastating complications of malig-
nant solid tumors. The short median survival time of pa-
tients with leptomeningeal metastases of solid tumors
may be insufficient for the development a chronic dis-
ease that leads to atrophy in the pons.
Based on the lack of signs of atrophy, we hypothesize
that the mechanism resulting in the HCB sign in the
present case differs from previous cases and may have
been due to neuronal damage caused by cerebral ische-
mia, neuronal nutritional deficiencies, metabolic abnor-
malities, and/or direct tumor invasion. For example,
leptomeningeal metastases from solid tumors can lead to
many pathophysiologic changes, including: 1) hydroceph-
alus or increased intracranial pressure due to blockade of
CSF flow; 2) neurologic dysfunction caused by tumor
compression or invasion of the brain and spinal cord; 3)
disrupted blood-CSF barrier; 4) tumor compression-
induced brain ischemia from the invasion of blood vessels
on the brain convexity and in the Virchow-Robin space,
which can cause vascular spasms, encephalopathy, and re-
duced blood supply [11]; and 5) metabolic disorder due to
competitive inhibition of cerebral glucose utilization by
the neuron [12].
Conclusions
In conclusion, this case report describes a rare appearance
of the HCB sign in a patient with leptomeningeal metasta-
ses of breast cancer, thus demonstrating that its appear-
ance is not limited to conditions characterized by regional
atrophy. The mechanisms underlying the HCB signs are
complex and remain to be explored in future studies.
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